WASHINGTON (Reuters) – Drugs reviewers said Astellas Pharma Inc’s treatment for an overactive bladder worked, but they raised concerns about liver and heart safety issues.
24/7 haber gündem piyasalar son dakika
WASHINGTON (Reuters) – Drugs reviewers said Astellas Pharma Inc’s treatment for an overactive bladder worked, but they raised concerns about liver and heart safety issues.